Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.This is an entirely free service. No payments are to be made.
Here you will find all the research and views that we post on Equitymaster. Use the tools to customize the results to suit your preference!
Meet the Superinvestors of India and know where are they directing their money to.
Chris Mayer talks about the businesses that will be the biggest wealth creators over the next two decades.
With a sound process based investment strategy, returns need not be compromised for safety.
Discriminate the fastest growing businesses between Sensex 20,000 and Sensex 30,000
Why even Warren Buffett would want to be in your shoes for buying smallcaps.
Replicating the success story of Joel Greenblatt in buying Indian microcap stocks today.
The secrets and track records of some of the little known super investors we came across, left us hugely impressed.
The trend that makes a select group of bluechip stocks inherently safer even at peak index valuations.
The government will invest Rs 3.96 trillion on infrastructure. Is steel the core investing opportunity?
A rare piece of wisdom from the latest Daily Journal annual meet.
Is skepticism about the management a golden opportunity to buy cash rich stocks like Infosys?
This lesser known Idea Cellular deal has some important lessons for investors.
We faced a similar situation in IT stocks in 2013 and 2014 and came to similar conclusions.
Whether the Budget could ruin chances of earnings recovery and deal a huge blow to valuations.
Bitcoin Glitters More Than Gold! Is this a new normal in safe heaven assets, after demonetisation?
Teaser loans could be the last nail in coffin of banks reeling under bad loan problem.
The answers to these questions will give us a better vision of 2017 and beyond...
The businesses that could become vulnerable with the potential collapse of India's exports.
The Challenge that Demonetisation is Posing Pharma sector stocks.